AC Immune (ACIU) Revenue Growth (1y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 64.24% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 7.82% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 19.04% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 3,790.58% |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | 29.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.77% |
| Dec 31, 2025 | -67.42% |
| Sep 30, 2025 | -96.01% |
| Jun 30, 2025 | 107.65% |
| Dec 31, 2020 | 20.17% |
| Sep 30, 2020 | -45.36% |
| Jun 30, 2020 | -25.41% |
| Mar 31, 2020 | -83.15% |
| Dec 31, 2019 | -22.86% |
| Sep 30, 2019 | -4.69% |
| Jun 30, 2019 | -26.86% |
| Mar 31, 2019 | 4,801.17% |
| Dec 31, 2018 | -92.06% |
| Sep 30, 2018 | 125.42% |
| Jun 30, 2018 | 153.74% |
| Mar 31, 2018 | -23.05% |
| Dec 31, 2017 | 837.24% |
| Sep 30, 2017 | -22.01% |
| Jun 30, 2017 | -94.37% |
| Mar 31, 2017 | 307.43% |
| Dec 31, 2016 | 125.64% |
| Sep 30, 2016 | -94.73% |
| Dec 31, 2015 | 810.82% |